Glycogenosis type Ib is an ultra-rare disease research hub

Evaluation of the efficacy and safety of empagliflozin in the treatment of neutropenia in patients with glycogenosis Ib. EMPAtia.

This study is looking at a medicine called empagliflozin (Jardiance) to see if it's safe and helpful for adults with a very rare condition called Glycogenosis type Ib. We want to find out if it can improve their low neutrophil count, which is a type of white blood cell.